Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · IEX Real-Time Price · USD

0.721

-0.049 (-6.36%)

At close: Apr 19, 2024, 3:59 PM

0.742

+0.021 (2.90%)

After-hours: Apr 19, 2024, 7:59 PM EDT

Aptevo Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-17.41	8.03	-28.46	-17.75	-40.45	-53.69	6.97	-112.42	-59.32	-51.12	Upgrade
Depreciation & Amortization	0.57	0.9	1.14	1.41	2.24	2.39	3.13	3.36	2.91	2.02	Upgrade
Share-Based Compensation	2.19	1.8	1.64	1.26	1.6	2.14	4.88	3.81	1.11	1.07	Upgrade
Other Operating Activities	2.92	-31.75	3.99	-14.23	-5.77	-2.26	-56.56	68.38	6.54	1.01	Upgrade
Operating Cash Flow	-11.73	-21.02	-21.68	-29.32	-42.38	-51.42	-41.57	-36.86	-48.76	-47.01	Upgrade
Capital Expenditures	0	-0.03	-0.71	-0.09	-0.15	-0.98	-1.4	-2.51	-1.53	-0.99	Upgrade
Acquisitions	0	0	0	28.12	4.25	0.07	59.76	0	0	-47.81	Upgrade
Change in Investments	0	0	0	0	0	73.71	-28.9	-44.88	0	0	Upgrade
Investing Cash Flow	0	-0.03	-0.71	28.03	4.1	72.8	29.46	-47.39	-1.53	-48.8	Upgrade
Share Issuance / Repurchase	9.48	6.93	11.44	21.26	20.34	0.62	0.44	0.04	0	0	Upgrade
Debt Issued / Paid	-3.47	-12.27	-10.55	2.63	-0.14	-0.6	-0.15	18.04	0	0	Upgrade
Other Financing Activities	-0.01	2.72	25.27	-0.01	-0.06	-0.81	19.24	71.22	51.33	99.4	Upgrade
Financing Cash Flow	6	-2.62	26.16	23.87	20.15	-0.79	19.53	89.3	51.33	99.4	Upgrade
Net Cash Flow	-5.73	-23.67	3.77	22.59	-18.14	20.59	7.42	5.04	1.04	3.59	Upgrade
Free Cash Flow	-11.73	-21.05	-22.39	-29.41	-42.54	-52.4	-42.98	-39.37	-50.29	-48	Upgrade
Free Cash Flow Margin	-	-676.01%	-182.17%	-682.43%	-	-227.16%	-293.18%	-394.33%	-149.66%	-105.18%	Upgrade
Free Cash Flow Per Share	-42.19	-181.60	-210.17	-381.57	-641.61	-1434.54	-1240.80	-1198.39	-1531.24	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).